{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T23:38:19Z","timestamp":1776296299929,"version":"3.50.1"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006507","name":"Funda\u00e7\u00e3o Oswaldo Cruz","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006507","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.bbrc.2025.152797","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T19:47:06Z","timestamp":1760730426000},"page":"152797","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Optimization of cationic functionalized nanoparticles for brain targeting: in vivo evaluation"],"prefix":"10.1016","volume":"788","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-8577-7335","authenticated-orcid":false,"given":"Kaique Alves Brayner","family":"Pereira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa Chamon Alves","family":"Premazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinicius","family":"de Lima Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno Jorge Duque","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3883-7714","authenticated-orcid":false,"given":"Carolina Baeta Salvador","family":"V\u00e1rady","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana Mello e","family":"Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo","family":"Muller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6381-8924","authenticated-orcid":false,"given":"Renata Chagas","family":"Bastos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia Regina Elias","family":"Mansur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2216-8624","authenticated-orcid":false,"given":"Patricia Barbosa","family":"Jurgilas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2025.152797_bib1","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/ana.23648","article-title":"The blood-brain barrier in health and disease","volume":"72","author":"Daneman","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbrc.2025.152797_bib2","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/JLB.1RU1117-428R","article-title":"Blood-brain barrier and its function during inflammation and autoimmunity","volume":"103","author":"Sonar","year":"2018","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bbrc.2025.152797_bib3","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.3390\/ijms23031851","article-title":"A review of the common neurodegenerative disorders: current therapeutic approaches and the potential role of nanotherapeutics","volume":"23","author":"Lamptey","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2025.152797_bib4","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1007\/s13311-022-01228-5","article-title":"Current chemical, biological, and physiological views in the development of successful brain-targeted pharmaceutics","volume":"19","author":"Markowicz-Piasecka","year":"2022","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.bbrc.2025.152797_bib5","doi-asserted-by":"crossref","first-page":"117","DOI":"10.12793\/tcp.2017.25.3.117","article-title":"Intracerebroventricular drug administration","volume":"25","author":"Atkinson","year":"2017","journal-title":"Transl. Clin. Pharmacol."},{"key":"10.1016\/j.bbrc.2025.152797_bib6","article-title":"On a highway to the brain: a review on nose-to-brain drug delivery using nanoparticles","volume":"29","author":"Formica","year":"2022","journal-title":"Appl. Mater. Today"},{"key":"10.1016\/j.bbrc.2025.152797_bib7","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2147\/IJN.S596","article-title":"Drug delivery and nanoparticles: applications and hazards","volume":"3","author":"de Jong","year":"2008","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.bbrc.2025.152797_bib8","first-page":"2088","article-title":"Nose to brain transport pathways an overview: potential of nanostructured lipid carriers in nose to brain targeting","volume":"46","author":"Selvaraj","year":"2018","journal-title":"Artif. Cells, Nanomed. Biotechnol."},{"key":"10.1016\/j.bbrc.2025.152797_bib9","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1039\/C5RA19793G","article-title":"Intranasal delivery of Asenapine loaded nanostructured lipid carriers: formulation, characterization, pharmacokinetic and behavioural assessment","volume":"6","author":"Singh","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.bbrc.2025.152797_bib10","doi-asserted-by":"crossref","first-page":"515","DOI":"10.4155\/tde-2018-0002","article-title":"Evidence for intranasal Oxytocin delivery to the brain: recent advances and future perspectives","volume":"9","author":"Quintana","year":"2018","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.bbrc.2025.152797_bib11","article-title":"Nanocarrier facilitated drug delivery to the brain through intranasal route: a promising approach to transcend bio-obstacles and alleviate neurodegenerative conditions","volume":"75","author":"Sastri","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.bbrc.2025.152797_bib12","doi-asserted-by":"crossref","first-page":"3870","DOI":"10.1016\/j.biomaterials.2013.02.003","article-title":"Lactoferrin-modified PEG-co-PCL nanoparticles for enhanced brain delivery of NAP peptide following intranasal administration","volume":"34","author":"Liu","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.bbrc.2025.152797_bib13","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1007\/s13346-020-00816-2","article-title":"Nose-to-brain drug delivery mediated by polymeric nanoparticles: influence of PEG surface coating","volume":"10","author":"de Oliveira Junior","year":"2020","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.bbrc.2025.152797_bib14","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1039\/c2cs15327k","article-title":"Design of polymeric nanoparticles for biomedical delivery applications","volume":"41","author":"Elsabahy","year":"2012","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.bbrc.2025.152797_bib15","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.eurpolymj.2015.01.016","article-title":"Smart polymers in drug delivery systems on crossroads: which way deserves following?","volume":"65","author":"Hrub\u00fd","year":"2015","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.bbrc.2025.152797_bib16","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ejpb.2018.05.022","article-title":"Influence of PLA-PEG nanoparticles manufacturing process on intestinal transporter Pept1 targeting and Oxytocin transport","volume":"129","author":"Gourdon","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.bbrc.2025.152797_bib17","doi-asserted-by":"crossref","first-page":"9182","DOI":"10.3390\/polym12091882","article-title":"Comparative nanofabrication of PLGA-Chitosan-PEG systems employing microfluidics and emulsification solvent evaporation techniques","volume":"12","author":"Essa","year":"2020","journal-title":"Polymers"},{"key":"10.1016\/j.bbrc.2025.152797_bib18","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/jps.23836","article-title":"Nose-to-brain delivery: evaluation of polymeric nanoparticles on olfactory ensheathing cells uptake","volume":"103","author":"Musumeci","year":"2014","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.bbrc.2025.152797_bib19","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jconrel.2020.02.020","article-title":"Recent strategies and advances in the fabrication of nano lipid carriers and their application towards brain targeting","volume":"321","author":"Agrawal","year":"2020","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.bbrc.2025.152797_bib20","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.3390\/polym12112589","article-title":"Tailoring Midazolam-loaded chitosan nanoparticulate formulation for enhanced brain delivery via intranasal route","volume":"12","author":"Shrestha","year":"2020","journal-title":"Polymers"},{"key":"10.1016\/j.bbrc.2025.152797_bib21","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1021\/acs.molpharmaceut.1c00366","article-title":"Structure and fate of nanoparticles designed for the nasal delivery of poorly soluble drugs","volume":"18","author":"Clementino","year":"2021","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bbrc.2025.152797_bib22","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.colsurfb.2017.01.031","article-title":"Nose-to-brain delivery of BACE1 siRNA loaded in solid lipid nanoparticles for Alzheimer's therapy","volume":"152","author":"Rassu","year":"2017","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.bbrc.2025.152797_bib23","doi-asserted-by":"crossref","DOI":"10.1088\/2632-959X\/ab9008","article-title":"Peptide based drug delivery systems to the brain","volume":"1","author":"Islam","year":"2020","journal-title":"Nano Express"},{"key":"10.1016\/j.bbrc.2025.152797_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119553","article-title":"Cationic biopolymer functionalized nanoparticles encapsulating Lutein to attenuate oxidative stress in effective treatment of Alzheimer's disease: a non-invasive approach","volume":"586","author":"Dhas","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bbrc.2025.152797_bib25","doi-asserted-by":"crossref","first-page":"8669","DOI":"10.1016\/j.biomaterials.2011.07.069","article-title":"A cascade targeting strategy for brain neuroglial cells employing nanoparticles modified with Angiopep-2 peptide and EGFP-EGF1 Protein","volume":"32","author":"Huile","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.bbrc.2025.152797_bib26","series-title":"Handbook of Nanoparticles","first-page":"941","article-title":"Nanoparticle functionalization for brain targeting drug delivery and diagnostic","author":"Gomes","year":"2016"},{"key":"10.1016\/j.bbrc.2025.152797_bib27","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.2217\/nnm-2018-0139","article-title":"Nanoparticle crossing of blood-brain barrier: a road to new therapeutic approaches to central nervous system diseases","volume":"13","author":"Ce\u00f1a","year":"2018","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.bbrc.2025.152797_bib28","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s40005-019-00442-2","article-title":"Pegylated polylactide (PLA) and Poly (lactic-co-glycolic acid) (PLGA) copolymers for the design of drug delivery systems","volume":"49","author":"Perinelli","year":"2019","journal-title":"J. Pharm. Investig."},{"key":"10.1016\/j.bbrc.2025.152797_bib29","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.ijpharm.2012.07.029","article-title":"Penetratin-functionalized PEG-PLA nanoparticles for brain drug delivery","volume":"436","author":"Xia","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bbrc.2025.152797_bib30","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.biomaterials.2012.09.044","article-title":"PEG-co-PCL nanoparticles modified with MMP-2\/9 activatable low molecular weight protamine for enhanced targeted glioblastoma therapy","volume":"34","author":"Gu","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.bbrc.2025.152797_bib31","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jconrel.2014.05.056","article-title":"Low molecular weight protamine (LMWP): a nontoxic protamine substitute and an effective cell-penetrating peptide","volume":"193","author":"He","year":"2014","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.bbrc.2025.152797_bib32","doi-asserted-by":"crossref","first-page":"9888","DOI":"10.1016\/j.biomaterials.2011.09.004","article-title":"Low molecular weight protamine-functionalized nanoparticles for drug delivery to the brain after intranasal administration","volume":"32","author":"Xia","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.bbrc.2025.152797_bib33","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jconrel.2014.06.051","article-title":"Low-molecular-weight protamine-modified PLGA nanoparticles for overcoming drug-resistant breast cancer","volume":"192","author":"Wang","year":"2014","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.bbrc.2025.152797_bib34","doi-asserted-by":"crossref","first-page":"9999","DOI":"10.1021\/acsnano.6b04268","article-title":"Blood-brain-barrier-penetrating albumin nanoparticles for biomimetic drug delivery via albumin-binding protein pathways for antiglioma therapy","volume":"10","author":"Lin","year":"2016","journal-title":"ACS Nano"},{"key":"10.1016\/j.bbrc.2025.152797_bib35","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ijpharm.2018.05.055","article-title":"The use of low molecular weight protamine to enhance oral absorption of Exenatide","volume":"547","author":"Zhang","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bbrc.2025.152797_bib36","first-page":"301","article-title":"Preparation, statistical optimization and characterization of Propolis-loaded solid lipid nanoparticles using Box-Behnken design","volume":"11","author":"Taherzadeh","year":"2021","journal-title":"Adv. Pharmaceut. Bull."},{"key":"10.1016\/j.bbrc.2025.152797_bib37","doi-asserted-by":"crossref","first-page":"E486","DOI":"10.1002\/adv.21295","article-title":"Optimizing the process parameters for encapsulation of Linamarin into PLGA nanoparticles using double emulsion solvent evaporation technique","volume":"32","author":"Hussein","year":"2013","journal-title":"Adv. Polym. Technol."},{"key":"10.1016\/j.bbrc.2025.152797_bib38","first-page":"S1555","article-title":"Formulation, optimization, and characterization of Amlodipine Besylate loaded polymeric nanoparticles","volume":"29","author":"Chourasiya","year":"2021","journal-title":"Polym. Polym. Compos."},{"key":"10.1016\/j.bbrc.2025.152797_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2022.111307","article-title":"Study of sonication parameters on PLA nanoparticles preparation by simple emulsion-evaporation solvent technique","volume":"173","author":"Ruiz","year":"2022","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.bbrc.2025.152797_bib40","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0927-7765(99)00156-3","article-title":"\u2018Stealth\u2019 corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption","volume":"18","author":"Gref","year":"2000","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.bbrc.2025.152797_bib41","doi-asserted-by":"crossref","first-page":"10748","DOI":"10.1039\/D1NR02065J","article-title":"Effects of polyethylene glycol on the surface of nanoparticles for targeted drug delivery","volume":"13","author":"Shi","year":"2021","journal-title":"Nanoscale"},{"key":"10.1016\/j.bbrc.2025.152797_bib43","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.jsps.2016.12.008","article-title":"Effect of cryoprotection on particle size stability and preservation of chitosan nanoparticles with and without Hyaluronate or alginate coating","volume":"25","author":"Almalik","year":"2017","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.bbrc.2025.152797_bib44","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.3762\/bjnano.8.144","article-title":"Cationic pegylated polycaprolactone nanoparticles carrying post-operation Docetaxel for glioma treatment","volume":"8","author":"Varan","year":"2017","journal-title":"Beilstein J. Nanotechnol."},{"key":"10.1016\/j.bbrc.2025.152797_bib45","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1016\/j.biomaterials.2006.01.038","article-title":"Lectin-conjugated PEG-PLA nanoparticles: preparation and brain delivery after intranasal administration","volume":"27","author":"Gao","year":"2006","journal-title":"Biomaterials"},{"key":"10.1016\/j.bbrc.2025.152797_bib46","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1039\/C7ME00059F","article-title":"Influence of mesopore size and peptide aggregation on the adsorption and release of a model antimicrobial peptide onto\/from mesoporous silica nanoparticles in vitro","volume":"2","author":"Braun","year":"2017","journal-title":"Mol. Syst. Des. Eng."},{"key":"10.1016\/j.bbrc.2025.152797_bib47","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3109\/03639045.2012.758130","article-title":"Preparation, characterization, in vivo biodistribution and pharmacokinetic studies of Donepezil-loaded PLGA nanoparticles for brain targeting","volume":"40","author":"Md","year":"2014","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.bbrc.2025.152797_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics12020097","article-title":"Development of Meloxicam-Human serum albumin nanoparticles for nose-to-brain delivery via application of a quality by design approach","volume":"12","author":"Katona","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bbrc.2025.152797_bib49","doi-asserted-by":"crossref","DOI":"10.1088\/1742-6596\/1375\/1\/012078","article-title":"Effect of solid lipid nanoparticles system on the stability of green tea leaves (Camellia Sinensis l. Kuntze) extract as sunscreen","volume":"1375","author":"Aryani","year":"2019","journal-title":"J. Phys. Conf. Ser."},{"key":"10.1016\/j.bbrc.2025.152797_bib50","first-page":"173","article-title":"Next-generation natural baby barrier cream formulations: physicochemical analysis and safety assessment","volume":"72","author":"Kurt","year":"2021","journal-title":"J. Cosmet. Sci."},{"key":"10.1016\/j.bbrc.2025.152797_bib51","first-page":"44","article-title":"Effect of different lipid ratios on physicochemical stability and drug release of nanostructured lipid carriers loaded Coenzyme Q10","volume":"10","author":"Suyuti","year":"2023","journal-title":"Pharmacy Pharm. Sci. J."},{"key":"10.1016\/j.bbrc.2025.152797_bib52","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jconrel.2005.03.027","article-title":"Cationic albumin-conjugated pegylated nanoparticles as novel drug carrier for brain delivery","volume":"107","author":"Lu","year":"2005","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.bbrc.2025.152797_bib53","doi-asserted-by":"crossref","first-page":"4943","DOI":"10.1016\/j.biomaterials.2011.03.031","article-title":"Targeting the brain with PEG-PLGA nanoparticles modified with phage-displayed peptides","volume":"32","author":"Li","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.bbrc.2025.152797_bib54","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1166\/jbn.2019.2724","article-title":"The trigeminal pathway dominates the nose-to-brain transportation of intact polymeric nanoparticles: evidence from aggregation-caused quenching probes","volume":"15","author":"Li","year":"2019","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.bbrc.2025.152797_bib55","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/j.apsb.2022.07.003","article-title":"Polymeric nanocarriers for nose-to-brain drug delivery in neurodegenerative diseases and neurodevelopmental disorders","volume":"13","author":"Awad","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bbrc.2025.152797_bib56","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.3390\/pharmaceutics13122049","article-title":"Nanotherapeutics for nose-to-brain drug delivery: an approach to bypass the blood brain barrier","volume":"13","author":"Lee","year":"2021","journal-title":"Pharmaceutics"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X2501513X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X2501513X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T04:52:53Z","timestamp":1769057573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X2501513X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":55,"alternative-id":["S0006291X2501513X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.152797","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimization of cationic functionalized nanoparticles for brain targeting: in vivo evaluation","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.152797","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152797"}}